We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New ELISA for Celiac Disease

By HospiMedica staff writers
Posted on 02 Jul 2001
An innovative anti-human transglutaminase (endomysium) enzyme-linked immunosorbent assay (ELISA) for serologic diagnosis of gluten-sensitive enteropathy (GSE, celiac disease) has been introduced.

Antibodies against transglutaminase occur with a prevalence of almost 100% in untreated GSE, whereas they are virtually never found in healthy individuals or patients with other intestinal diseases. More...
The new ELISA is based on a human endomysium whole antigen, which is superior to transglutaminase from guinea pig liver and human recombinant enzyme as an ELISA antigen substrate. Whereas ELISA systems based on guinea pig transglutaminase show a correlation of only 73% with the "gold standard” indirect immunofluorescence test, this new ELISA demonstrates a correlation of 95% in various studies. Discrepancies only occurred with low-titer sera. In sera with moderate to high titers, the correlation was 100%.

The new ELISA is suitable for confirming a clinical diagnosis of symptomatic celiac disease, revealing latent celiac disease—which is more than three times as prevalent as the symptomatic form—and identifying a disposition to GSE in relatives of celiac disease patients. The assay was developed by Euroimmun GmbH (Luebeck, Germany).




Related Links:
Euroimmun

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.